DAY 1

Session 1: Introductory presentations (Chaired by Tony West)

• Philosophy behind PAT and efficient generation of analytical data
  Gerd Fischer, Sanofi-Aventis
• Stability testing using a matrix approach
  Andrew Battle, Covance

Session 2: Stability Session

• A risk based approach to establish stability testing conditions for tropical countries
  Manuel Zahn, AstraZeneca
• Automation to support degradation in early phase drug development
  Charles Wigfall, Wyeth

Session 3: PAT Session (Chaired by Paul Graham)

• Developments and opportunities in PAT
  David Radspinner, Thermo Electron
• Examples of PAT being used to support sterile manufacturing
  Lyn Crawford, Wyeth
• Process Analytical Technology; the Pfizer philosophy
  Neville Broad, Bronwyn Grout, Steve Hammond - Pfizer

DAY 2

Session 4: PASG Young Persons Session (Chaired by Adele Patterson)

• Process miniaturisation; a route to knowledge generation
  Steve Haswell, Hull University
• Mainteance of the GSK screening collection; description of stability experiments and high throughput LC-MS  
  QA analysis
  Zoe Blaxhill, BMS
• On-line monitoring of wet granulation processes using acoustic emission
  John Gamble, BMS
• Speed, sensitivity and selectivity; evaluation of the use of LC-MS in pharmaceutical development
  Emma Simmonds, Sanofi Aventis
• Fast temperature gradients by resistive heating for LC applications
  Fiona Harvey-Doyle, Loughborough University 

Session 5: Stability continued  (Chaired by John Andrews)

• Validation of novel analytical technologies for stability testing
  Tony Fell, University of Bradford

Session 6: Stability continued (Chaired by John Andrews)

• Assessing the stability of an amorphous drug-polymer dispersion
  Anne Kavanagh, AstraZeneca